Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
378746-64-6COc1c(N2C[C@@H](C)C[C@H](N)C2)ccc2c(=O)c(C(=O)O)cn(C3CC3)c12AVPQPGFLVZTJOR-RYUDHWBXSA-N378746-64-6DTXSID10958907CHEMBL1213456CHEBI:136053BeschreibungNemonoxacin is a novel nonfluorinated quinolone and broad-spectrum antibiotic for the treatment of drug-resistant bacterial infections, including methicillin-resistant Staphylococcus aureus (MRSA) and quinolone- resistant MRSA as well as quinolone-resistant Streptococcus pneumonia. The drug was originally discovered by Procter & Gamble Pharmaceuticals (P&GP). It was codeveloped by TaiGen Biotechnology for development in Asia and by Warner Chilcott for development in the United States and Europe and was first approved by the China Food and Drug Administration (CFDA).
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Wird geladen…